| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR2500102235 |
Jinling Hospital, Medical School of Nanjing University |
Esophageal Carcinoma |
|
|
2025-05-12 | 163 | Patient list |
| 12345 |
North District, The First Affiliated Hospital of Anhui Medical University (Anhui Provincial Public Health Clinical Center) |
Esophageal Cancer |
Therapy Study |
Post-market |
2024-03-24 | 598 | Patient list |
| ChiCTR2200066726 |
Affiliated Hospital of North Sichuan Medical College |
esophageal cancer |
Therapy Study |
|
2023-05-12 | 785 | Patient list |
| ChiCTR2100051846 |
Affiliated Hospital of Southwest Medical University |
Esophageal cancer |
Therapy Study |
|
2021-11-14 | 973 | Patient list |
| ChiCTR2100048917 |
Neoadjuvant PD-1 inhibitor plus chemotherapy in resectable esophageal cancer Department of Thoracic Surgery,Tangdu Hospital, Air Force Medical University |
resectable esophageal cancer |
Therapy Study |
Post-market |
2021-07-24 | 1189 | Patient list |
| ChiCTR2100046715 |
Sichuan Cancer Hospital & Institute |
esophagus cancer |
Therapy Study |
Post-market |
2021-06-08 | 1374 | Patient list |
| ChiCTR2000034996 |
using organoid to simulate and study the pathogenesis of esophageal cancer west china hospital of sichuan university |
esophageal precancerous lesion and esophageal cancer |
Therapy Study |
Premarket |
2020-07-26 | 1373 | Patient list |
| ChiCTR2000034294 |
Sun Yat-sen University Cancer Center |
Esophageal cancer |
|
|
2020-07-01 | 1517 | Patient list |
| ChiCTR2000031971 |
West China Hospital, Sichuan University |
Esophageal cancer |
Therapy Study |
|
2020-04-20 | 1409 | Patient list |
| ChiCTR2000030111 |
|
esophageal cancer |
Therapy Study |
Post-market |
2020-02-23 | 1273 | Patient list |